指南与共识细菌感染、耐药与抗菌药物艾滋病与性传播感染

美国淋病奈瑟菌感染管理:2020年淋病治疗推荐制定及2021年美国疾病控制与预防中心性传播感染治疗指南的证据总结

Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines.
指南 / 共识 · Clin Infect Dis · 2022-01-01

美国CDC基于2013至2019年文献综述及淋球菌分离株监测项目数据,制定了2020年淋病治疗推荐和2021年性传播感染治疗指南。GISP数据显示美国头孢曲松最低抑菌浓度保持稳定,但对阿奇霉素最低抑菌浓度≥2.0 mcg/mL的分离株比例2018年升至近5%。2021年指南推荐无并发症淋病所有解剖部位单次肌注头孢曲松500mg,未排除衣原体合并感染时加用多西环素100mg每日两次共7天;头孢菌素过敏者替代疗法有限,咽部淋病奈瑟菌感染无推荐替代疗法。

要点

  • 2021年CDC指南推荐无并发症淋病所有解剖部位单次肌注头孢曲松500mg。
  • 未排除衣原体合并感染时,应加用多西环素100mg每日两次共7天。
  • GISP数据显示对阿奇霉素最低抑菌浓度≥2.0 mcg/mL的分离株比例2018年升至近5%。

核心结论

  • 2021年CDC性传播感染治疗指南推荐无并发症淋病所有解剖部位单次肌注头孢曲松500mg。
  • 未排除衣原体合并感染时,应加用多西环素100mg每日两次共7天。
  • 头孢菌素过敏者替代疗法有限,咽部淋病奈瑟菌感染无推荐替代疗法。

研究设计与样本

  • 淋病主题专家提出8个关键问题,对2013至2019年淋病抗菌药物耐药、治疗失败、临床试验等更新数据进行文献综述。
  • 评估超过2200篇摘要,彻底审查248篇临床相关文章。
  • 专家还评估了淋球菌分离株监测项目(GISP)的淋病奈瑟菌抗菌药物耐药数据。

主要发现

  • 国际上有头孢曲松治疗失败报告,但GISP数据提示美国头孢曲松最低抑菌浓度保持稳定,<0.1%的分离株呈现「警示值」最低抑菌浓度(>0.25 mcg/mL)。
  • GISP记录到对阿奇霉素最低抑菌浓度升高(≥2.0 mcg/mL)的分离株比例快速上升,2018年近5%。

关键数值与推荐

  • 2021年CDC性传播感染治疗指南推荐无并发症淋病所有解剖部位单次肌注头孢曲松500mg。
  • 未排除衣原体合并感染时,应加用多西环素100mg每日两次共7天。
  • 头孢菌素过敏者替代疗法有限;咽部淋病奈瑟菌感染无推荐替代疗法。

临床怎么用

  • 无并发症淋病所有解剖部位推荐单次肌注头孢曲松500mg治疗。
  • 未排除衣原体合并感染时,应加用多西环素100mg每日两次共7天。
  • 头孢菌素过敏者替代疗法有限,咽部淋病奈瑟菌感染无推荐替代疗法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Neisseria gonorrhoeae has developed resistance to all first-line recommended therapies, making gonococcal antimicrobial resistance a major public health concern given limited antibiotic options currently and an even smaller antimicrobial development pipeline. Since the release of the Centers for Disease Control and Prevention (CDC) 2015 STD Treatment Guidelines, azithromycin, part of the 2015 dual-drug treatment regimen, has had a rapid rise in resistance. The 2020 CDC Gonorrhea Treatment Recommendations and the 2021 Sexually Transmitted Infections (STI) Treatment Guidelines were developed weighing the priorities of treating the individual, protecting the population, and preventing antimicrobial resistance. METHODS: Gonorrhea subject matter experts (SME) generated 8 key questions and conducted a literature review of updated data from 2013 to 2019 on gonorrhea antimicrobial resistance, treatment failures, clinical trials, and other key topics. More than 2200 abstracts were assessed, and 248 clinically relevant articles were thoroughly reviewed. SMEs also evaluated N gonorrhoeae antimicrobial resistance data from the Gonococcal Isolate Surveillance Project (GISP). EVIDENCE: Although there have been reports of ceftriaxone treatment failures internationally, GISP data suggest that ceftriaxone minimal inhibitory concentrations (MICs) have remained stable in the United States, with < 0.1% exhibiting an "alert value" MIC (> 0.25 mcg/mL). However, GISP documented a rapid rise in the proportion of isolates with an elevated MIC (≥ 2.0 mcg/mL) to azithromycin-nearly 5% in 2018. At the same time, new pharmacokinetic/pharmacodynamic data are available, and there is greater recognition of the need for antimicrobial stewardship. SUMMARY: The 2021 CDC STI Treatment Guidelines now recommend 500mg ceftriaxone intramuscularly once for the treatment of uncomplicated gonorrhea at all anatomic sites. If coinfection with chlamydia has not been excluded, cotreatment with doxycycline 100mg twice daily for 7 days should be added. Few alternative therapies exist for persons with cephalosporin allergies; there are no recommended alternative therapies for N gonorrhoeae infection of the throat.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Barbee LA, St Cyr SB. Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines. Clin Infect Dis. 2022. PMID: 35416971. doi:10.1093/cid/ciac043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。